Anna Schollhorn

Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Vaccination Against RhoC in Prostate Cancer Patients Induces Potent and Long-Lasting CD4+ T Cell Responses with Cytolytic Potential in the Absence of Clinical Efficacy: A Randomized Phase II Trial.

Vaccination Against RhoC in Prostate Cancer Patients Induces Potent and Long-Lasting CD4+ T Cell Responses with Cytolytic Potential in the Absence of Clinical Efficacy: A Randomized Phase II Trial.

Journal: Vaccines

Published: January 21, 2025

Staining of activated ß2-integrins in combination with CD137 and CD154 for sensitive identification of functional antigen-specific CD4+ and CD8+ T cells.

Staining of activated ß2-integrins in combination with CD137 and CD154 for sensitive identification of functional antigen-specific CD4+ and CD8+ T cells.

Journal: Frontiers in immunology

Published: November 24, 2022

CAF-immune cell crosstalk and its impact in immunotherapy.

CAF-immune cell crosstalk and its impact in immunotherapy.

Journal: Seminars in immunopathology

Published: October 04, 2022

Integrin activation enables rapid detection of functional Vδ1+ and Vδ2+ γδ T cells.

Integrin activation enables rapid detection of functional Vδ1+ and Vδ2+ γδ T cells.

Journal: European journal of immunology

Published: October 13, 2021

Common virulence gene expression in adult first-time infected malaria patients and severe cases.

Common virulence gene expression in adult first-time infected malaria patients and severe cases.

Journal: eLife

Published: April 06, 2021

CD4+ T Cells: Multitasking Cells in the Duty of Cancer Immunotherapy.

CD4+ T Cells: Multitasking Cells in the Duty of Cancer Immunotherapy.

Journal: Cancers

Published: December 28, 2020

Integrin Activation Enables Sensitive Detection of Functional CD4+ and CD8+ T Cells: Application to Characterize SARS-CoV-2 Immunity.

Integrin Activation Enables Sensitive Detection of Functional CD4+ and CD8+ T Cells: Application to Characterize SARS-CoV-2 Immunity.

Journal: Frontiers in immunology

Published: November 05, 2020

Cyanobacterial antimetabolite 7-deoxy-sedoheptulose blocks the shikimate pathway to inhibit the growth of prototrophic organisms.

Cyanobacterial antimetabolite 7-deoxy-sedoheptulose blocks the shikimate pathway to inhibit the growth of prototrophic organisms.

Journal: Nature communications

Published: July 10, 2018

Showing 1-8 of 8

Last Updated: 09/26/2026